← Eichor
Condition: Perimenopausal Bone Loss Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Perimenopausal Bone Loss

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Combined Anabolic Therapy
Phase 4 · 1 location(s) · Massachusetts General Hospital · NCT06558188Effect of Mechanical Loading and Bone Loss on Motor Neuron Activity-H-Reflex Relationship
NA · 1 location(s) · Istanbul Physical Medicine Rehabilitation Training and Resea · NCT07253493Evaluation of Adherence With Bisphosphonates and Calcium and Vitamin D Supplements in Women With Postmenopausal Osteopor
Phase N/A · 21 location(s) · Procare Health Iberia S.L. · NCT07105163Mechanisms of Anabolic Osteoporosis Therapy
NA · 1 location(s) · Massachusetts General Hospital · NCT05688969Virtual perI-/Menopause Registry of AusTrALia
Phase N/A · 1 location(s) · Bespoke Clinical Research · NCT06487130Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients
Phase 4 · 1 location(s) · National Taiwan University Hospital · NCT06938152StrAtegies For Zoledronic Acid Post-dEnosumab Discontinuation in Postmenopausal oSTeoporosis
Phase 4 · 17 location(s) · University Hospital, Toulouse · NCT06767150Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis
Phase N/A · 1 location(s) · Beylikduzu State Hospital · NCT06655701Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis
NA · 1 location(s) · Khyber Medical University Peshawar · NCT07242612Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females
Phase 1 · 1 location(s) · University of Connecticut · NCT07365514Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal Osteoporosis
NA · 7 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT05571514Health Literacy's Impact on Exercise Habits and Medication Adherence in Postmenopausal Osteoporosis
Phase N/A · 1 location(s) · Gazi University · NCT06462833Vascular Function, Sarcopenia and Pain in Postmenopausal Osteoporosis
NA · 1 location(s) · University Hospital, Clermont-Ferrand · NCT05228262Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis
Phase 4 · 1 location(s) · National Taiwan University Hospital · NCT07283887Sequential Therapies After Osteoanabolic Treatment
Phase N/A · 8 location(s) · 424 General Military Hospital · NCT06164795Prunes Preventing Bone Loss in Perimenopause
NA · 1 location(s) · Penn State University · NCT07120997New Biomarkers and Therapeutic Targets in Osteoporosis Via Omics Technologies
Phase N/A · 1 location(s) · National and Kapodistrian University of Athens · NCT06525688Can Serum Lumican Level Identify a Hidden Fragility Phenotype Beyond Bone Mineral Density in Postmenopausal Women?
Phase N/A · 1 location(s) · Kanuni Sultan Suleyman Training and Research Hospital · NCT07677072MicroRNA and Markers and Therapeutic Response to Romosozumab and Abaloparatide in Postmenopausal Osteoporosis
NA · 2 location(s) · Istituto Auxologico Italiano · NCT07616401Orthorexia Nervosa in Postmenopausal Osteoporosis
Phase N/A · 1 location(s) · Beylikduzu State Hospital · NCT06947213COMPASS - COpenhagen MenoPAuSe Study
Phase 2 · 1 location(s) · Martin Blomberg Jensen · NCT07254429The Investigation of the Effectiveness of Virtual Reality Applications in Postmenopausal Osteoporosis Patients
NA · 1 location(s) · Kirsehir Ahi Evran Universitesi · NCT07231822
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.